News Snapshot:
Brazil Health Regulator Anvisa Allows Chinese COVID-19 Vaccine Trial By Reuters , Wire Service Content July 3, 2020 By Reuters , Wire Service Content July 3, 2020, at 10:54 p.m. FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration Reuters SAO PAULO (Reuters) - Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China's Sinovac, according to an official gazette publication. The study - first announced on June 11 - is led by...
